Add to the pain and fear of eating, a $650/month copay because I didn't meet the medical criteria for taking a GLP-1, and it really was a losing proposition for me
(60) utilized next generation sequencing (NGS) and computational analysis to demonstrate that miR-23b-3p, acting as a tumor suppressor, can inhibit tumor Gln metabolism by targeting GLS1, thereby enhancing the sensitivity of liver tumor cells to sorafenib
Last updated 16 October 2025
The research also comes as drug manufacturers face scrutiny over labeling drug side effects
[18] Gene-expression profiling shows it upregulates collagen types I, III, and IV and suppresses MMPs, mirroring retinol's effects via separate mechanisms
Dhanapalaratnam R, Issar T, Lee ATK, Poynten AM, Milner K-L, Kwai NCG, Krishnan AV